192 related articles for article (PubMed ID: 17265058)
1. A new evidence for the maintenance of the sarcoglycan complex in muscle sarcolemma in spite of the primary absence of delta-SG protein.
Gouveia TL; Kossugue PM; Paim JF; Zatz M; Anderson LV; Nigro V; Vainzof M
J Mol Med (Berl); 2007 Apr; 85(4):415-20. PubMed ID: 17265058
[TBL] [Abstract][Full Text] [Related]
2. Epsilon-sarcoglycan compensates for lack of alpha-sarcoglycan in a mouse model of limb-girdle muscular dystrophy.
Imamura M; Mochizuki Y; Engvall E; Takeda S
Hum Mol Genet; 2005 Mar; 14(6):775-83. PubMed ID: 15689353
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of sarcoglycans, vinculin-talin-integrin system and filamin2 in alpha- and gamma-sarcoglycanopathy: an immunohistochemical study.
Anastasi G; Cutroneo G; Trimarchi F; Santoro G; Bruschetta D; Bramanti P; Pisani A; Favaloro A
Int J Mol Med; 2004 Dec; 14(6):989-99. PubMed ID: 15547664
[TBL] [Abstract][Full Text] [Related]
4. Different outcome of sarcoglycan missense mutation between human and mouse.
Henriques SF; Patissier C; Bourg N; Fecchio C; Sandona D; Marsolier J; Richard I
PLoS One; 2018; 13(1):e0191274. PubMed ID: 29360879
[TBL] [Abstract][Full Text] [Related]
5. Sarcoglycanopathies: can muscle immunoanalysis predict the genotype?
Klinge L; Dekomien G; Aboumousa A; Charlton R; Epplen JT; Barresi R; Bushby K; Straub V
Neuromuscul Disord; 2008 Dec; 18(12):934-41. PubMed ID: 18996010
[TBL] [Abstract][Full Text] [Related]
6. Beta-sarcoglycan gene mutations in Turkey.
Balci B; Wilichowski E; Haliloğlu G; Talim B; Aurino S; Kremer E; Ebinger F; Senbil N; Anlar B; Kale G; Nigro V; Topaloğlu H; Bonnemann C; Dinçer P
Acta Myol; 2004 Dec; 23(3):154-8. PubMed ID: 15938573
[TBL] [Abstract][Full Text] [Related]
7. Sarcoglycan subcomplex in normal and pathological human muscle fibers.
Anastasi G; Cutroneo G; Rizzo G; Favaloro A
Eur J Histochem; 2007; 51 Suppl 1():29-33. PubMed ID: 17703591
[TBL] [Abstract][Full Text] [Related]
8. Gamma-sarcoglycan is required for the response of archvillin to mechanical stimulation in skeletal muscle.
Spinazzola JM; Smith TC; Liu M; Luna EJ; Barton ER
Hum Mol Genet; 2015 May; 24(9):2470-81. PubMed ID: 25605665
[TBL] [Abstract][Full Text] [Related]
9. Assembly of the sarcoglycan complex. Insights for muscular dystrophy.
Holt KH; Campbell KP
J Biol Chem; 1998 Dec; 273(52):34667-70. PubMed ID: 9856984
[TBL] [Abstract][Full Text] [Related]
10. Zeta-sarcoglycan is a functional homologue of gamma-sarcoglycan in the formation of the sarcoglycan complex.
Shiga K; Yoshioka H; Matsumiya T; Kimura I; Takeda S; Imamura M
Exp Cell Res; 2006 Jul; 312(11):2083-92. PubMed ID: 16635485
[TBL] [Abstract][Full Text] [Related]
11. Beta-sarcoglycanopathy (LGMD 2E) in a Spanish family.
Rivas E; Teijeira S; dos Santos MR; Porrit I; Leturcq F; Fernandez JM; Navarro C
Acta Myol; 2004 Dec; 23(3):159-62. PubMed ID: 15938574
[TBL] [Abstract][Full Text] [Related]
12. Alpha-sarcoglycan is recycled from the plasma membrane in the absence of sarcoglycan complex assembly.
Draviam RA; Wang B; Shand SH; Xiao X; Watkins SC
Traffic; 2006 Jul; 7(7):793-810. PubMed ID: 16787395
[TBL] [Abstract][Full Text] [Related]
13. Recombinant adeno-associated virus type 8-mediated extensive therapeutic gene delivery into skeletal muscle of alpha-sarcoglycan-deficient mice.
Nishiyama A; Ampong BN; Ohshima S; Shin JH; Nakai H; Imamura M; Miyagoe-Suzuki Y; Okada T; Takeda S
Hum Gene Ther; 2008 Jul; 19(7):719-30. PubMed ID: 18578595
[TBL] [Abstract][Full Text] [Related]
14. Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan.
Shi W; Chen Z; Schottenfeld J; Stahl RC; Kunkel LM; Chan YM
Muscle Nerve; 2004 Mar; 29(3):409-19. PubMed ID: 14981741
[TBL] [Abstract][Full Text] [Related]
15. The 16 kDa subunit of vacuolar H+-ATPase is a novel sarcoglycan-interacting protein.
Chen J; Skinner MA; Shi W; Yu QC; Wildeman AG; Chan YM
Biochim Biophys Acta; 2007 May; 1772(5):570-9. PubMed ID: 17382524
[TBL] [Abstract][Full Text] [Related]
16. Specific knockdown of delta-sarcoglycan gene in C2C12 in vitro causes post-translational loss of other sarcoglycans without mechanical stress.
Honda M; Hosoda M; Kanzawa N; Tsuchiya T; Toyo-oka T
Mol Cell Biochem; 2009 Mar; 323(1-2):149-59. PubMed ID: 19083155
[TBL] [Abstract][Full Text] [Related]
17. Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.
Rodino-Klapac LR; Lee JS; Mulligan RC; Clark KR; Mendell JR
Neurology; 2008 Jul; 71(4):240-7. PubMed ID: 18525034
[TBL] [Abstract][Full Text] [Related]
18. CFTR corrector C17 is effective in muscular dystrophy, in vivo proof of concept in LGMDR3.
Scano M; Benetollo A; Nogara L; Bondì M; Dalla Barba F; Soardi M; Furlan S; Akyurek EE; Caccin P; Carotti M; Sacchetto R; Blaauw B; Sandonà D
Hum Mol Genet; 2022 Feb; 31(4):499-509. PubMed ID: 34505136
[TBL] [Abstract][Full Text] [Related]
19. The sarcoglycan complex in skeletal muscle.
Tarakci H; Berger J
Front Biosci (Landmark Ed); 2016 Jan; 21(4):744-56. PubMed ID: 26709803
[TBL] [Abstract][Full Text] [Related]
20. A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.
Herson S; Hentati F; Rigolet A; Behin A; Romero NB; Leturcq F; Laforêt P; Maisonobe T; Amouri R; Haddad H; Audit M; Montus M; Masurier C; Gjata B; Georger C; Cheraï M; Carlier P; Hogrel JY; Herson A; Allenbach Y; Lemoine FM; Klatzmann D; Sweeney HL; Mulligan RC; Eymard B; Caizergues D; Voït T; Benveniste O
Brain; 2012 Feb; 135(Pt 2):483-92. PubMed ID: 22240777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
